Log In
Print
BCIQ
Print
Print this Print this
 

hGH-CTP, Lagova (MOD-4023)

  Manage Alerts
Collapse Summary General Information
Company Opko Health Inc.
DescriptionLong-acting human growth hormone (hGH) combined with the company's carboxyl terminal peptide (CTP) technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase III
Standard IndicationGrowth hormone deficiency
Indication DetailsTreat growth hormone deficiency (GHD)
Regulatory Designation

U.S. - Orphan Drug (Treat growth hormone deficiency (GHD))

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today